法洛四联症修复术中限制性扩大肺动脉瓣环:十年随访对比研究
本研究比较了限制性扩大肺动脉瓣环策略(仅当肺动脉瓣环z-score小于-2时使用跨瓣环补片)与全国非统一策略队列的法洛四联症修复患者。结果显示限制性策略显著降低跨瓣环补片率(32.2% vs 64.7%),提高十年免于因肺动脉瓣反流再手术率(98% vs 92%),并减小右心室容积和反流分数。
要点
- 限制性扩大肺动脉瓣环可降低跨瓣环补片使用率。
- 该策略提高十年免于因肺动脉瓣反流再手术率。
- 限制性策略与更小的右心室容积和更低的反流分数相关。
核心结论
- 限制性扩大肺动脉瓣环可减少肺动脉瓣反流并限制右心室扩张,且再手术需求显著低于同期队列。
主要发现
- Group 1跨瓣环补片率显著低于Group 2(32.2% vs 64.7%,P < 0.001)。
- Group 1十年免于因肺动脉瓣反流再手术率显著高于Group 2(98% vs 92%,P = 0.01)。
- 多变量分析显示限制性扩大是无需再手术的唯一预测因素(风险比0.4,95%CI 0.24-0.84,P < 0.01)。
- Group 1的心脏磁共振指标更优: indexed end-diastolic volume 103 ± 24 vs 123 ± 31 ml/m2,P < 0.001;indexed end-systolic volume 53 ± 19 vs 59 ± 20 ml/m2,P = 0.04;反流分数21 ± 14 vs 31 ± 17%,P < 0.001。
关键数值与推荐
- 限制性扩大策略中,仅当肺动脉瓣环z-score小于-2时使用跨瓣环补片。
临床怎么用
- 在法洛四联症修复术中,可采用限制性扩大肺动脉瓣环策略以减少肺动脉瓣反流和再手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Since 1996, our centre performs restrictive enlargement of the pulmonary annulus at surgical repair of tetralogy of Fallot. A transannular patch is only used if the z-score of the pulmonary annulus is smaller than -2. We sought to determine whether this strategy reduces pulmonary insufficiency (PI) and reoperation rate compared to a nationwide contemporary cohort that has not been operated using a uniform strategy. METHODS: Eighty-seven tetralogy of Fallot patients were included in the study (Group 1). One hundred sixty-seven tetralogy of Fallot patients from the Competence Network for Congenital Heart Disease served as controls (Group 2). Clinical, echocardiographic, electrocardiogram, cardiovascular magnetic resonance and outcome data were analysed. RESULTS: Follow-up time since repair was not different between groups [12.9 (7.8-18.8) vs 13.1 (5.2-16.9) years, P = 0.96] while transannular patch rate was significantly lower in Group 1 (32.2% vs 64.7%, P < 0.001). Ten-year freedom from reoperation for PI was significantly higher in our cohort (98% vs 92%, P = 0.01). Multivariable analysis identified restrictive enlargement as the only predictor for no need of reoperation [hazard ratio 0.4 (95% confidence interval 0.24-0.84), P < 0.01]. In Group 1, cardiovascular magnetic resonance-derived volumes were smaller (indexed end-diastolic volume: 103 ± 24 vs 123 ± 31 ml/m2, P < 0.001; indexed end-systolic volume: 53 ± 19 vs 59 ± 20 ml/m2, P = 0.04) and regurgitation fraction was lower (21 ± 14 vs 31 ± 17%, P < 0.001). CONCLUSIONS: Restrictive enlargement of the pulmonary annulus reduces PI and limits the amount of right ventricular dilatation at intermediate-term follow-up. The need for reoperation to alleviate PI is significantly lower compared to a contemporary cohort. Restrictive enlargement strategy has a stronger influence on freedom from reoperation than the use of a transannular patch. CLINICAL TRIAL REGISTRATION: WHO Main ID: DRKS00010087. URL: http://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00010087.
引用
- Logoteta J, Dullin L, Hansen JH, et al. Restrictive enlargement of the pulmonary annulus at repair of tetralogy of Fallot: a comparative 10-year follow-up study. Eur J Cardiothorac Surg. 2017. PMID: 28549113. doi:10.1093/ejcts/ezx143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。